This workshop is made possible through a generous sponsorship from Henry Schein® Dental.

Detection, Diagnosis, and Treatment Strategies


Oral cavity and oropharyngeal cancers are on the rise. The American Cancer Society most recently estimates about 58,450 new cases and 12,230 deaths in the U.S. in 2024 from oral cavity and oropharyngeal cancer.1 Improving early detection and treatment is essential!

This hands-on certification workshop is your best first step in 2024 to the frontline of the fight against oral cancer. Made possible through a partnership with Henry Schein Dental, these sessions are crafted specifically for clinical oral health professionals. Refresh what you know and build your skills to help your patients through early detection, diagnosis and treatment.


ADHA Members $275
Nonmembers $325
Up to 6.5 Live CE Credits

Saturday, April 27, 2024
8:00 am – 5:00 pm
Full-Day In-Person Workshop
Hyatt Regency Jersey City, NJ

Hygienists save lives. To ensure your thorough understanding of oral cancers, you’ll start with an oral pathology deep-dive based on essential aspects from new case statistics. Learn to recognize and identify early signs and symptoms, decipher clinical and radiographic presentations, and develop a differential diagnosis for oral cancers that can save lives.

Master the oral exam. Practice and update your own clinical skills for conducting a comprehensive oral examination. Learn to excel at early detection, deliver accurate diagnosis and identify contemporary treatment options for oral cavity and oropharyngeal cancers.

Hands-on Diagnostic Certification Lab
Product image_Viome Oral Health Pro with Cancer DetectRound out the diagnostic skills session with hands-on training in cutting-edge early diagnosis and monitoring point-of-care salivary technology used to detect biomarkers associated with oral and throat cancers. Seated at roundtables, you’ll be trained with hands-on practice to use the Oral Health ProTM with CancerDetectTM diagnostic product by VIOME. Earn your certification in this revolutionary technology that can help dental professionals identify patients who are at risk for oral squamous cell carcinoma and oropharyngeal squamous cell carcinoma.

Step up to the frontline of defense and improve the survival rate. Get that deeper understanding of oral cancer pathology, detection, diagnosis and treatment, and be empowered with the clinical skills to contribute more effectively to interdisciplinary team communications, oral and oropharyngeal cancer management and care, and positive outcomes for your patients.

Subject to Change. 

8:00 AM – 8:45 AM
Registration and Breakfast

8:45 AM – 9:00 AM
Welcome and Opening Remarks

9:00 AM – 11:00 AM | 2.0 CE
Overview of Oral Pathology, Part 1
Dr. Ross Kerr

— A.M. BREAK, 11:00 AM – 11:15 AM —

11:15 AM – 12:30 PM | 1.25 CE
Overview of Oral Pathology, Part 2
Dr. Ross Kerr


1:15 PM – 3:00 PM | 1.75 CE
Comprehensive Oral Exam “It’s More Than Grasping The Tongue”
Susan Cotten, BSDH, RDH, OMT

— P.M. BREAK, 3:00 PM – 3:15 PM —

3:15 PM – 4:45 PM | 1.5 CE
Salivary Diagnostics Hands-on Lab
Featuring Viome testing kits
Dr. Bruce Lieberthal, Chief Innovation Officer at Henry Schein
with Guruduth Banavar, PhD, Chief Technology Officer and Head of Discovery AI at Viome Life Sciences, Inc.

4:45 PM – 5:00 PM
Closing Remarks

Up to 6.5 Live CE Credits*

* State stipulations on live CE change occasionally. Check with your state for specific guidelines.

Who should attend this workshop?

This course is ideal for clinicians who currently perform oral cancer screenings or are looking to integrate screenings and diagnostics into their clinical practice!

  • If oral cancer screening and diagnosis is already part of your routine, this workshop will arm you with the latest insights and an advanced diagnostic technique with a comprehensive oral examination and pathology review, plus a brush-up of your approach to diagnosis and treatment.
  • If oral cancer screening, diagnostics and treatment modalities are areas of growth and opportunity for you, use this full-day immersion to gain an in-depth understanding of oral cavity and oropharyngeal cancers, comprehensive oral examination techniques for early detection and learn about diagnosis and treatment approaches.

Workshop Speakers

Susan Cotten, BSDH, RDH, OMT

Susan Cotten, BSDH, RDH, OMT

Susan is CEO of Oral Cancer Consulting and developed the “Cotten Method”, an oral cancer screening method and dental office system. She speaks on oral cancer and holds hands-on oral cancer screening workshops for dental professionals who want to have more confidence in screening, reduce the risk of liability, and increase early detection. In her career, Susan has performed over 60 thousand oral cancer screenings. She is the Dental Lead for the Alliance for HPV Free Colorado, developing and delivering training on HPV, the HPV vaccine, and HPV oropharyngeal cancer. She is an RDH Advisory Board member at The Oral Cancer Foundation, a Director with Dental Codeology Consortium, instructor at National Network for Healthcare Hygienists, and a published author.

In 2020, Susan received the Ethyl Covington Award from the Colorado Dental Hygiene Association/CODHA. She is a 2018 recipient of the Sunstar RDH Award of Distinction and CODHA Outstanding Contribution Award. Susan founded MAD(Make A Difference) for Healthy Smiles as a 2010-2011 member of Donny Osmond’s Make a Difference program and received Volunteer of the Year from the Oral Cancer Foundation in 2011.


Dr. Bruce LieberthalBruce Lieberthal, DDS

Dr. Lieberthal serves as the Chief Innovation Officer for Henry Schein, Inc.  In this role, he is at the nexus of evaluating hundreds of cutting edge solutions and technologies, advising the many medical and dental business units of Henry Schein on important emerging trends and helping connect the company’s global sales, marketing and distribution capabilities with important new products that help its customers run better practices and deliver excellent patient care.

He has held various positions with Henry Schein, Inc., including Vice President of Emerging Technologies, Vice President of Product Management and Development and had oversight responsibility for Henry Schein Medical Systems (MicroMD) between 2011 and 2017, led the ConnectDental team, focused on the launch of Henry Schein’s digital dentistry business and currently leads Henry Schein One’s DDX business.

Bruce graduated SUNY Buffalo’s School of Dentistry in 1983 and practiced dentistry for 14 years between 1984 and 1997. Bruce also serves on the boards of The Forsyth Institute and the Harvard School of Dental Medicine.


Dr. A. Ross KerrA. Ross Kerr, DDS, MSD, FDS, RCPS

Dr. Kerr is a Clinical Professor in the Department of Oral and Maxillofacial Pathology, Radiology and Medicine at NYU College of Dentistry and in the Department of Otolaryngology at NYU Langone Health Center.

Dr. Kerr received his DDS from McGill University in Montreal, Canada, and his MSD and certificate in Oral Medicine at the University of Washington. He is a recipient of NYU’s distinguished teaching award. He is a past president of the American Academy of Oral Medicine, director of the American Board of Oral Medicine, steering committee member of the World Workshop on Oral Medicine, member of the executive committee of the European Association of Oral Medicine, and member of the Scientific Advisory Board for the Oral Cancer Foundation.

His research experience includes the evaluation of current and emerging technologies for the detection and diagnosis of oral cancer and oral potentially malignant disorders. He has contributed more than 100 publications to the dental and medical literature.

This is a full-day hands-on course taking place at the tranquil waterfront Hyatt Regency Jersey City on the Hudson facing the iconic Manhattan skyline.

Hyatt Regency Jersey City on the Hudson
Two Exchange Place
Jersey City, New Jersey 07302

View Hotel Parking & Transportation

Travel, transportation, accommodations and parking for this event are the registrant’s responsibility. For information on hotel accommodations, please contact ADHA Meetings & Conventions at [email protected].

Upon completion of the program, you will be able to:

  1. Interpret current oral cancer statistics analyzing factors influencing oral cancer rates.
  2. Recognize early signs and symptoms of oral cancer.
  3. Develop a differential diagnosis for oral cancers based on clinical and radiographic information.
  4. Identify contemporary treatment options for oral cavity and oropharyngeal cancers.
  5. Appreciate prognosis considerations and factors influencing treatment outcomes.
  6. Develop practical skills for conducting a comprehensive oral examination.
  7. Recognize the importance of a thorough oral examination in early detection of oral cancers.
  8. Explore the potential of salivary biomarkers in early diagnosis and monitoring.
  9. Foster effective communication among healthcare professionals involved in oral cancer care.
  10. Appreciate the value of interdisciplinary communication in the management of oral cancers.

1. Key Statistics for Oral Cavity and Oropharyngeal Cancers. (2024). American Cancer Society. Retrieved January 25, 2024, from